BBC Health 25 Oct 2026
Wellbeing support demand for cancer patients grows
Macmillan Cancer Support Jersey publishes its annual report looking back at 2025.
25 Oct 2026
Read →
These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
This observational study will target patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) who have started treatment with bimekizumab, upadacitinib, risankizumab,…
Prostate cancer is now the most common cancer in men in the Western world. In the United Kingdom (UK), there were over…
Elranatamab is a bispecific antibody: binding of elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells causes targeted T-cell-mediated cytotoxicity. The main…
This is a multi-center, open label, phase II study of tebentafusp in patients with unresectable or metastatic clear cell sarcoma (CCS).
The trial will be a phase III, randomised-controlled, multi-centre, international, open-label trial consisting of ruxolitinib versus best available therapy, where best available…
The purpose of this study is to understand the safety, tolerability, efficacy, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy of orally administered…
Your patient insight is valuable. Take a short survey and help researchers improve treatments for Cancer.
Living with Cancer? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Cancer. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Cancer patients.
TA1202
TA1197
📋 Information sourced from clinical trial registries, FDA, EMA and published research
View all research →No podcasts available yet for Cancer
Sign up for updates below to be notified when we release a free patient podcast for this area.